ArticleCommunications medicine2026
Gestational weight gain and adverse perinatal outcomes among individuals with gestational diabetes.
Article in Communications medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Relationship Between Pre-Pregnancy Body Mass Index, Gestational Weight Gain, and Perinatal Outcomes Among Women Delivering at a General Hospital, Nakhon Si Thammarat Province.International journal of environmental research and public health · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe relationship between gestational weight gain and perinatal outcomes in women with gestational diabetes remains inadequately studied, and specific weight gain recommendations are lacking for this population.
methodsWe conducted a retrospective cross-sectional study by extracting natality data from the National Center for Health Statistics (NCHS) of the Centers for Disease Control and Prevention in the United States, including 1,368,789 record (2015-2020) as the main sample and 280,165 (2021) as the validation sample. The composite adverse outcome is defined as a composite of gestational hypertension or preeclampsia, primary cesarean delivery, maternal transfusion, maternal intensive care admission, preterm birth<37 weeks, small or large size for gestational age at birth and neonatal intensive care unit admission. Optimal gestational weight gain ranges were estimated for each pre-pregnancy body mass index category through multivariable logistic regression model to identify the odds ratio targets at which any adverse outcome decreased. Model discrimination was evaluated using area under the receiver operating characteristic curve.
resultsAdverse outcomes occur in 52.67% of pregnancies, with incidence rising substantially with body mass index (44.28% in normal weight vs 67.08% in class 3 obesity). The optimal gestational weight gain ranges are: underweight (12.0- < 20.0 kg), normal weight (8.0- < 16.0 kg), overweight (weight loss-<14 kg), class 1 obesity (weight loss-<10.0 kg) and obesity classes 2-3 (weight loss <8.0 kg). These ranges demonstrate low to moderate discrimination between affected and unaffected pregnancies (ranges of area under the receiver operating characteristic curve, 0.57-0.68).
conclusionsMinimal weight gain or weight loss is associated with a decreased risk of adverse perinatal outcomes among women with overweight or obesity complicated by gestational diabetes.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.